MED (Medifast) Total Equity: $197.7 Mil (As of Mar. 2026)


MED Medifast Inc MED
70 GF Score
Price $10.51
GF Value $8.75
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast Total Equity?

Medifast MED +3.04% 70 Total Equity is $197.7 Mil as of Mar. 2026. GuruFocus rates MED with a GF Score™ of 70/100 and a GF Value™ of $8.75 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Medifast's total equity for the quarter that ended in Mar. 2026 was $197.7 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Medifast Total Equity Historical Data

* Premium members only.

The historical data trend for Medifast's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast Total Equity Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202.47 155.04 201.48 210.11 198.92

Medifast Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.96 216.01 214.71 198.92 197.68
MED
70GF Score
Medifast Inc MED
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Medifast's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=247.973-49.053
=198.9

Medifast's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=252.046-54.365
=197.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $197.7 Mil mean?
Medifast (MED) has a Total Equity of $197.7 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Medifast and its competitors.
Is Medifast's Total Equity too high?
Medifast's current Total Equity is $197.7 Mil. Overall, Medifast has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Total Equity compare to RGS and VGES?
Medifast's Total Equity of $197.7 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Personal Services company?
A good Total Equity depends on the Personal Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Medifast and its competitors. Medifast's current Total Equity is $197.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (MED) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.75, compared to a current price of $10.51 — trading 20.1% above its estimated fair value. The current Total Equity is $197.7 Mil. Medifast's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Medifast (MED), the current Total Equity is $197.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of $10.51 is trading 20.1% above its estimated GF Value™ of $8.75. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for MED:

  • Total Equity: $197.7 Mil
  • GF Value™: $8.75 vs. price of $10.51 (20.1% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medifast Business Description

Other Exchanges 0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
70GF Score

Get the complete analysis for MED

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.51
Price
$8.75
GF Value